The Biggest Questions From the HBO-Dominated 2023 Emmy Nominations
‘The Washington Post’ Names Alex MacCallum Chief Revenue Officer
Shutterstock, OpenAI Pen A New 6-Year Deal
Google Engaged In ‘Mass Theft’ To Train AI, Lawsuit Alleges
How Abercrombie & Fitch Is Celebrating Differences and Championing Authenticity
Why These Bombs Are Banned by Over Half the World | WSJ Equipped
Roku Expands FreeWheel Deal, Enables Access To More Ad Inventory
Why pharma marketers are leaning into impression-based TV buying
Chris Rooney, pharmaceutical lead, client vertical sales, DISH Media
As streaming TV continues to win greater audience share, pharma marketers are using impression-based buying to drive DTC connections and build incremental reach. According to Statista, the healthcare and pharmaceutical industry’s digital ad spend will reach $19.66 billion by the end of 2024.
By leveraging the deterministic data, analytics and closed-loop measurement now available within the advanced television ecosystem, pharma companies are achieving a win-win: the scale of linear TV with the targeted messaging precision of digital. Pharmaceutical brands are leaning heavily into data-driven ad buying to drive brand impact.
Continue reading this article on digiday.com. Sign up for Digiday newsletters to get the latest on media, marketing and the future of TV.